Katelyn Cassidy

Katelyn Cassidy is currently serving as the Lead Proteomics Scientist at C4 Therapeutics, Inc. since October 2021. Prior to this role, Katelyn worked at AstraZeneca as a Senior Scientist in Chemical Biology from April 2019 to October 2021. With a background in Biochemistry, Katelyn conducted their PhD research at Dartmouth College, focusing on the biological networks involving E3 ubiquitin ligase HUWE1. Katelyn has also held research positions at Cubist Pharmaceuticals, EPIX Pharmaceuticals, and Pfizer, showcasing extensive experience in the pharmaceutical industry.